Skip to content

Clinical trials

Completed Tuberculosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberculosis Status: Completed Country / region: United States Clear all

109 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20011
20032
20044
20053
20064
20075
20082
20095
20108
20111
20129
20133
20145
20154
20166
20174
20196
20203
20213
20223
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed109

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)29
Centers for Disease Control and Prevention17
Global Alliance for TB Drug Development12
Johns Hopkins University4
QIAGEN Gaithersburg, Inc4
Sequella, Inc.3
Texas Tech University Health Sciences Center3
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections2
Aeras2
Otsuka Pharmaceutical Development & Commercialization, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberculosis109
HIV Infections21
Tuberculosis, Pulmonary14
Acquired Immunodeficiency Syndrome12
AIDS-Related Opportunistic Infections11
Latent Tuberculosis6
AIDS-Related Complex5
Lung Diseases4
Tuberculosis, Multidrug-Resistant4
Mycobacterium Infections3

Trials

Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.

9 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.